Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K1 | Q92918 | 14/20 | 0.58 |
| ▸ | LCP2 | Q13094 | 5/20 | 0.55 |
| ▸ | RPS6KA2 | Q15349 | 3/20 | 0.52 |
| ▸ | PRKD2 | Q9BZL6 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30233182 | 0.88 | MAP4K1 (0.74) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL25099897 | 0.88 | MAP4K1 (0.74) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261410 | 0.87 | LCP2 (0.56) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL30233384 | 0.87 | MAP4K1 (0.58) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261387 | 0.86 | LCP2 (0.55) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261355 | 0.86 | MAP4K1 (0.58) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261313 | 0.85 | LCP2 (0.61) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261239 | 0.84 | MAP4K1 (0.66) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261215 | 0.84 | MAP4K1 (0.59) | MAP4K1LCP2RPS6KA2PRKD2 | |
| SCHEMBL29261339 | 0.83 | LCP2 (0.78) | MAP4K1LCP2RPS6KA2PRKD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103369-A | Pyridolactam derivatives, preparation method and application thereof | 浙江海正药业股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2023030478-A1 | PYRIDOLACTAM DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 浙江海正药业股份有限公司 | 2023-03-09 | — | — | WO | disclosed |